...
首页> 外文期刊>Archives of Toxicology >Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity
【24h】

Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity

机译:肝3D培养物而非2D培养物保留了对乙酰氨基酚引起的肝毒性的特定转运蛋白活性

获取原文
获取原文并翻译 | 示例

摘要

Primary human hepatocytes (PHH) are the "gold standard" for in vitro toxicity tests. However, 2D PHH cultures have limitations that are due to a time-dependent dedifferentiation process visible by morphological changes closely connected to a decline of albumin production and CYP450 activity. The 3D in vitro culture corresponds to in vivo-like tissue architecture, which preserves functional characteristics of hepatocytes, and therefore can at least partially overcome the restrictions of 2D cultures. Consequently, several drug toxicities observed in vivo cannot be reproduced in 2D in vitro models, for example, the toxic effects of acetaminophen. The objective of this study was to identify molecular differences between 2D and 3D cultivation which explain the observed toxicity response. Our data demonstrated an increase in cell death after treatment with acetaminophen in 3D, but not in 2D cultures. Additionally, an acetaminophen concentration-dependent increase in the CYP2E1 expression level in 3D cultures was detected. However, during the treatment with 10 mM acetaminophen, the expression level of SOD gradually decreased in 3D cultures and was undetectable after 24 h. In line with these findings, we observed higher import/export rates in the membrane transport protein, multidrug resistance-associated protein-1, which is known to be specific for acetaminophen transport. The presented data demonstrate that PHH cultured in 3D preserve certain metabolic functions. Therefore, they have closer resemblance to the in vivo situation than PHH in 2D cultures. In consequence, 3D cultures will allow for a more accurate hepatotoxicity prediction in in vitro models in the future.
机译:原代人肝细胞(PHH)是体外毒性试验的“金标准”。然而,二维PHH培养具有局限性,这是由于随时间变化的去分化过程所致,这种变化可通过与白蛋白产量和CYP450活性下降密切相关的形态变化来观察。 3D体外培养对应于体内样组织结构,该结构保留了肝细胞的功能特征,因此可以至少部分克服2D培养的局限性。因此,在2D体外模型中无法重现体内观察到的几种药物毒性,例如对乙酰氨基酚的毒性作用。这项研究的目的是确定2D和3D培养之间的分子差异,这可以解释观察到的毒性反应。我们的数据表明,对乙酰氨基酚治疗3D后细胞死亡增加,而2D培养中则没有。另外,检测到对乙酰氨基酚浓度依赖性地增加了3D培养物中CYP2E1的表达水平。但是,在用10 mM对乙酰氨基酚处理期间,SOD的表达水平在3D培养物中逐渐降低,并且在24 h后无法检测到。根据这些发现,我们观察到了膜转运蛋白,多药耐药相关蛋白-1的较高的进出口速率,该蛋白已知对乙酰氨基酚转运具有特异性。呈现的数据表明,以3D培养的PHH保留了某些代谢功能。因此,它们比2D培养物中的PHH更接近体内情况。因此,将来3D培养物可以在体外模型中更准确地预测肝毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号